booom!! what been waiting for. great work NOX. commerical deals in USA on the horizon.
U.S. Food and
Drug Administration (FDA) has approved the Investigational New Drug (IND) application for
Veyonda® for combination treatment with doxorubicin in patients with soft tissue sarcomas.
FDA for being a safe and well-tolerated drug.”
Ann: FDA grants IND approval to Veyonda, page-2
Add NOX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
12.5¢ |
Change
0.020(19.1%) |
Mkt cap ! $36.52M | |||
| Open | High | Low | Value | Volume |
| 11.0¢ | 12.5¢ | 11.0¢ | $10.59K | 85.43K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 473711 | 11.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 12.5¢ | 99999 | 1 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| NOX (ASX) Chart |